Veru (VERU) Current Leases (2019 - 2026)
Veru (VERU) posted quarterly Current Leases of $770257.0 for Q1 2026, up 2.98% year-over-year from $747951.0 in Q1 2025, and up 0.74% quarter-over-quarter from $764590.0 in Q4 2025.
Veru (VERU) Current Leases (2019 - 2026) Analysis & Trends
Veru (VERU) has reported Current Leases for 8 consecutive years, with $770257.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Leases rose 2.98% year-over-year to $770257.0; the TTM figure through Mar 2026 stood at $770257.0 (up 2.98% YoY), while the FY2025 annual figure was $758946.0, up 2.98% from the prior year.
- Current Leases climbed to $770257.0 in Q1 2026 per VERU's latest filing, from $764590.0 in the prior quarter.
- Across five years, Current Leases topped out at $1.1 million in Q1 2023 and bottomed at $736970.0 in Q3 2024.
- Historically, Current Leases has averaged $900379.8 across 5 years, with a median of $951574.0 in 2022.
- Annual changes were most pronounced in 2022 — Current Leases jumped 111.03% — and 2024, when it declined 28.9%.
- Veru's Current Leases stood at $983253.0 in 2022, then climbed by 6.11% to $1.0 million in 2023, then decreased by 28.84% to $742449.0 in 2024, then increased by 2.98% to $764590.0 in 2025, then rose by 0.74% to $770257.0 in 2026.
- Business Quant data shows VERU's Current Leases at $770257.0 in Q1 2026, $764590.0 in Q4 2025, and $758946.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Veru | 60.85 Mn | 35.06 Mn | - | 775,157.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 775,157.00 |
| Mar 31, 2026 | 770,257.00 |
| Dec 31, 2025 | 764,590.00 |
| Sep 30, 2025 | 758,946.00 |
| Jun 30, 2025 | 753,400.00 |
| Mar 31, 2025 | 747,951.00 |
| Dec 31, 2024 | 742,449.00 |
| Sep 30, 2024 | 736,970.00 |
| Jun 30, 2024 | 1.04 Mn |
| Mar 31, 2024 | 1.04 Mn |
| Dec 31, 2023 | 1.04 Mn |
| Sep 30, 2023 | 1.04 Mn |
| Jun 30, 2023 | 1.06 Mn |
| Mar 31, 2023 | 1.08 Mn |
| Dec 31, 2022 | 983,253.00 |
| Sep 30, 2022 | 957,085.00 |
| Jun 30, 2022 | 951,574.00 |
| Mar 31, 2022 | 838,340.00 |
| Dec 31, 2021 | 465,921.00 |
| Sep 30, 2021 | 497,903.00 |